Prior to vaccine availability, RSV was a significant cause of illness and hospitalization in older adults in the U.S., ...

Respiratory syncytial virus is a common, highly contagious illness that often causes mild upper respiratory symptoms, akin to a cold. In babies, particularly those with tiny airways, RSV can cause the ...

High uptake of RSVpreF vaccine and nirsevimab was observed, with 64% of pregnant individuals and 70% of infants receiving ...

The respiratory syncytial virus (RSV) vaccine produced strong immune responses in older adults during its first two seasons of use, according to a new study.

Pregnant women can now get the maternal RSV vaccine, Abrysvo, for free under the National Immunisation Program (NIP), alongside ones for influenza and whooping cough. Abrysvo is available for ...

MRNA's earnings and revenues surpass estimates in the fourth quarter of 2024. The company reiterates 2025 total revenue ...

The federal government is investing $174.5m to provide eligible pregnant women with the RSV vaccine, Abrysvo, under the National Immunisation Program from Monday. This new vaccine will help protect ...

Pregnant women across the Northern Territory now have free access to protection against a virus that is the leading cause of hospitalisation for babies. The federal government is investing $174.5m ...

In the US Food and Drug Administration (FDA) study, officials combed through vaccine reaction data on two RSV jabs, called Abrysvo and Arexvy, documented between May 2023 and July last year.